Stock Analiz

MDT vs LIVN stock comparison

Medtronic vs. LivaNova · data as of November 13, 2026

Medtronic (MDT) has a market value of about $131.6B, LivaNova (LIVN) about $5.0B. Over their latest twelve months Medtronic had revenue of $37.5B and LivaNova $1.5B.

On our five checks Medtronic scores higher: 2.2 out of 5 (weak) against 2.0 (weak).

By area, the stronger company is LivaNova on future growth; LivaNova on financial health; Medtronic on shareholder returns.

Medtronic is cheaper on earnings (P/E 25.3 vs. 26.2), while LivaNova grew revenue faster over five years (8.2% vs. 3.8% a year).

Medtronic leads on 13 of the compared lines and LivaNova on 8.

Side by side

MDTLIVN
Size and price
Market cap$131.6B$5.0B
Share price$102.86$91.32
Score
Overall score (of 5)2.22.0
Value00
Future growth24
Track record11
Financial health34
Shareholder returns51
Valuation
P/E (TTM)25.326.2
Forward P/E17.320.8
Price / free cash flow21.539.0
Price / sales3.53.3
EV / EBITDA15.523.2
PEG3.61—
DCF value vs. price−16%−72%
Business
Revenue$37.5B$1.5B
Net income$5.2B$196M
Free cash flow$6.1B$129M
Net margin13.9%13.0%
Gross margin (5-yr avg.)65.9%67.7%
ROIC (5-yr avg.)6.0%1.6%
Growth
Revenue growth (1 yr)8.4%10.7%
Revenue growth (5 yrs, per year)3.8%8.2%
EPS growth (5 yrs, per year)7.0%—
Balance sheet and payouts
Net cash (cash minus debt)-$19.3B$210M
Dividend yield2.80%None
Shareholder yield3.6%0.0%
Analysts
Upside to average target+2%+15%
Consensus ratingBuyBuy

Highlighted = the better figure on that line. Revenue, net income and free cash flow: MDT TTM to July 31, 2026, LIVN TTM to September 30, 2026. Not investment advice.

Frequently asked questions

Which is the better stock, Medtronic or LivaNova?

We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) Medtronic scores 2.2 out of 5 and LivaNova 2.0; the table shows where each one is stronger.

Is Medtronic cheaper than LivaNova?

On trailing earnings, Medtronic trades at a P/E of 25.3 and LivaNova at 26.2, so Medtronic is cheaper by this measure. A lower P/E can also reflect slower expected growth.

Which grows faster, Medtronic or LivaNova?

Over five years LivaNova grew revenue about 8.2% a year and Medtronic about 3.8% a year.

Which pays a higher dividend?

Medtronic yields 2.80% and LivaNova nothing (no dividend).

Full Medtronic analysis → Full LivaNova analysis →

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.